SSH - WYANDOTTE — History
CCN 232031 | 3-year financial timeline | COVID resilience: 28/100
🛡️ Public data only — no PHI permitted on this instance.
$36M
Latest Revenue (FY2022)
-3.8%
Revenue CAGR (3yr)
11.2%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $39M | $37M | $36M | -3.0% | -3.8% |
| Operating Expenses | $30M | $36M | $32M | -9.9% | +3.2% |
| Operating Margin | 22.8% | 4.4% | 11.2% | +153.9% | -29.9% |
| Net Income | $9M | $2M | $4M | +146.2% | -32.5% |
| Licensed Beds | 71 | 71 | 71 | +0.0% | +0.0% |
| Total Patient Days | 20,521 | 19,283 | 17,982 | -6.7% | -6.4% |
| Medicare Day % | 39% | 34% | 40% | +14.9% | +1.1% |
| Medicaid Day % | 4% | 1% | 1% | +16.2% | -57.6% |
COVID Impact & Recovery
Resilience Score: 28/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -7.4% ($39M → $36M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-3.8%
This Hospital
+7.6%
State Avg
Latest Margin
11.2%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $35M | 5.4% |
| FY2024 (proj) | $33M | -0.4% |
| FY2025 (proj) | $32M | -6.2% |